•  
  •  
 

Abstract

Bisphenol analogs are widely used as replacements for bisphenol A (BPA), yet the understanding of their estrogenic potential and mechanisms of estrogen receptor (ER) interaction remain incomplete. This study evaluated the estrogenic activity of multiple bisphenol compounds and a potential green replacement bisguaiacol-F (BGF) using a yeast-based estrogen receptor reporter assay and examined the relationship between functional activity and molecular docking predictions. BGF is a derivative of lignin, a byproduct of paper production. A genetically engineered Saccharomyces cerevisiae strain expressing human ERα (hERα) and an estrogen-responsive reporter was used to determine ligand-dependent hERα transcriptional activity and used to calculate EC₅₀ values relative to BPA. Several bisphenol analogs induced dose response curves in in the yeast model, while BPS and BGF did not exhibit receptor activity. The rank order of estrogenicity using EC50 values is as follows:Estrogen >> BPC > BPB = BPF > BPAF > BPA = BPE > DHBP > Benzophenone. Molecular docking studies were performed using AutoDock Vina and LigPlot to identify potential binding affinity and interactions between bisphenol ligands and amino acid residues in the ligand-binding domain of ERα. Compounds that produced the highest levels of receptor activation in the yeast assay showed the strongest agreement between docking interactions and biological activity, whereas compounds with weaker predicted binding affinities displayed poor correlation with functional outcomesOur findings indicate that ER computational binding predictions do not uniformly translate to transcriptional activation and underscore the importance of integrating functional assays with computational modeling. Our results also suggest that BGF is a potentially safer alternative to bisphenols. The combined use of a yeast-based ER reporter system and molecular docking provides a more comprehensive framework for evaluating the estrogenic potential of bisphenol analogs.

Included in

Life Sciences Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.